Literature DB >> 33560326

Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review.

Jeffrey N Katz1,2,3, Kaetlyn R Arant1, Richard F Loeser4.   

Abstract

Importance: Osteoarthritis (OA) is the most common joint disease, affecting an estimated more than 240 million people worldwide, including an estimated more than 32 million in the US. Osteoarthritis is the most frequent reason for activity limitation in adults. This Review focuses on hip and knee OA. Observations: Osteoarthritis can involve almost any joint but typically affects the hands, knees, hips, and feet. It is characterized by pathologic changes in cartilage, bone, synovium, ligament, muscle, and periarticular fat, leading to joint dysfunction, pain, stiffness, functional limitation, and loss of valued activities, such as walking for exercise and dancing. Risk factors include age (33% of individuals older than 75 years have symptomatic and radiographic knee OA), female sex, obesity, genetics, and major joint injury. Persons with OA have more comorbidities and are more sedentary than those without OA. The reduced physical activity leads to a 20% higher age-adjusted mortality. Several physical examination findings are useful diagnostically, including bony enlargement in knee OA and pain elicited with internal hip rotation in hip OA. Radiographic indicators include marginal osteophytes and joint space narrowing. The cornerstones of OA management include exercises, weight loss if appropriate, and education-complemented by topical or oral nonsteroidal anti-inflammatory drugs (NSAIDs) in those without contraindications. Intra-articular steroid injections provide short-term pain relief and duloxetine has demonstrated efficacy. Opiates should be avoided. Clinical trials have shown promising results for compounds that arrest structural progression (eg, cathepsin K inhibitors, Wnt inhibitors, anabolic growth factors) or reduce OA pain (eg, nerve growth factor inhibitors). Persons with advanced symptoms and structural damage are candidates for total joint replacement. Racial and ethnic disparities persist in the use and outcomes of joint replacement. Conclusions and Relevance: Hip and knee OA are highly prevalent and disabling. Education, exercise and weight loss are cornerstones of management, complemented by NSAIDs (for patients who are candidates), corticosteroid injections, and several adjunctive medications. For persons with advanced symptoms and structural damage, total joint replacement effectively relieves pain.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33560326      PMCID: PMC8225295          DOI: 10.1001/jama.2020.22171

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  96 in total

Review 1.  The role of synovitis in osteoarthritis pathogenesis.

Authors:  Carla R Scanzello; Steven R Goldring
Journal:  Bone       Date:  2012-02-22       Impact factor: 4.398

2.  Prevalence of knee symptoms and radiographic and symptomatic knee osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project.

Authors:  Joanne M Jordan; Charles G Helmick; Jordan B Renner; Gheorghe Luta; Anca D Dragomir; Janice Woodard; Fang Fang; Todd A Schwartz; Lauren M Abbate; Leigh F Callahan; William D Kalsbeek; Marc C Hochberg
Journal:  J Rheumatol       Date:  2007-01       Impact factor: 4.666

3.  Synovitis and the risk of knee osteoarthritis: the MOST Study.

Authors:  D T Felson; J Niu; T Neogi; J Goggins; M C Nevitt; F Roemer; J Torner; C E Lewis; A Guermazi
Journal:  Osteoarthritis Cartilage       Date:  2015-09-30       Impact factor: 6.576

4.  Comparative effectiveness of glucosamine, chondroitin, acetaminophen or celecoxib for the treatment of knee and/or hip osteoarthritis: a network meta-analysis.

Authors:  Xiaoyue Zhu; Dandong Wu; Lingli Sang; Yidan Wang; Yi Shen; Xun Zhuang; Minjie Chu; Liying Jiang
Journal:  Clin Exp Rheumatol       Date:  2018-01-31       Impact factor: 4.473

5.  Prevalence, incidence and progression of hand osteoarthritis in the general population: the Framingham Osteoarthritis Study.

Authors:  Ida K Haugen; Martin Englund; Piran Aliabadi; Jingbo Niu; Margaret Clancy; Tore K Kvien; David T Felson
Journal:  Ann Rheum Dis       Date:  2011-05-27       Impact factor: 19.103

6.  A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis.

Authors:  Roy M Fleischmann; Henning Bliddal; Francisco J Blanco; Thomas J Schnitzer; Charles Peterfy; Su Chen; Li Wang; Sheng Feng; Philip G Conaghan; Francis Berenbaum; Jean-Pierre Pelletier; Johanne Martel-Pelletier; Ole Vaeterlein; Gurjit S Kaeley; Wei Liu; Matthew P Kosloski; Gwen Levy; Lanju Zhang; Jeroen K Medema; Marc C Levesque
Journal:  Arthritis Rheumatol       Date:  2019-06-07       Impact factor: 10.995

Review 7.  Inflammation in joint injury and post-traumatic osteoarthritis.

Authors:  J Lieberthal; N Sambamurthy; C R Scanzello
Journal:  Osteoarthritis Cartilage       Date:  2015-11       Impact factor: 6.576

8.  What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients.

Authors:  Andrew David Beswick; Vikki Wylde; Rachael Gooberman-Hill; Ashley Blom; Paul Dieppe
Journal:  BMJ Open       Date:  2012-02-22       Impact factor: 2.692

9.  Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis.

Authors:  Mikala C Osani; Raveendhara R Bannuru
Journal:  Korean J Intern Med       Date:  2019-03-15       Impact factor: 2.884

Review 10.  Prognostic factors for progression of clinical osteoarthritis of the knee: a systematic review of observational studies.

Authors:  Alex N Bastick; Jos Runhaar; Janneke N Belo; Sita M A Bierma-Zeinstra
Journal:  Arthritis Res Ther       Date:  2015-06-08       Impact factor: 5.156

View more
  110 in total

1.  Evaluation of cartilage degeneration using multiparametric quantitative ultrashort echo time-based MRI: an ex vivo study.

Authors:  Hongda Shao; Jiawei Yang; Yajun Ma; Xiaolian Su; Guangyu Tang; Junjie Jiang; Jiang Du; Jianjun Liu
Journal:  Quant Imaging Med Surg       Date:  2022-03

Review 2.  Musculoskeletal pain in Parkinson's disease: a narrative review.

Authors:  Lauren Elizabeth Tueth; Ryan P Duncan
Journal:  Neurodegener Dis Manag       Date:  2021-08-19

3.  The effect of an anti-inflammatory in comparison with a low caloric diet on physical and mental health in overweight and obese women with knee osteoarthritis: a randomized clinical trial.

Authors:  Neda Dolatkhah; Vahideh Toopchizadeh; Sahel Barmaki; Yagoub Salekzamani; Afsaneh Najjari; Azizeh Farshbaf-Khalili; Sanam Dolati
Journal:  Eur J Nutr       Date:  2022-10-02       Impact factor: 4.865

4.  [Indirubin relieves inflammatory injury of chondrocytes in a mouse model of osteoarthritis].

Authors:  X Chen; X Qi; Y Cao; Y Li; H Li; Q Wang; J Ai
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-09-20

Review 5.  Consensus Guidelines on Interventional Therapies for Knee Pain (STEP Guidelines) from the American Society of Pain and Neuroscience.

Authors:  Corey W Hunter; Timothy R Deer; Mark R Jones; George C Chang Chien; Ryan S D'Souza; Timothy Davis; Erica R Eldon; Michael F Esposito; Johnathan H Goree; Lissa Hewan-Lowe; Jillian A Maloney; Anthony J Mazzola; John S Michels; Annie Layno-Moses; Shachi Patel; Jeanmarie Tari; Jacqueline S Weisbein; Krista A Goulding; Anikar Chhabra; Jeffrey Hassebrock; Chris Wie; Douglas Beall; Dawood Sayed; Natalie Strand
Journal:  J Pain Res       Date:  2022-09-08       Impact factor: 2.832

Review 6.  Cell-based therapies have disease-modifying effects on osteoarthritis in animal models. A systematic review by the ESSKA Orthobiologic Initiative. Part 1: adipose tissue-derived cell-based injectable therapies.

Authors:  Carlotta Perucca Orfei; Angelo Boffa; Yosef Sourugeon; Lior Laver; Jérémy Magalon; Mikel Sánchez; Thomas Tischer; Giuseppe Filardo; Laura de Girolamo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-09-14       Impact factor: 4.114

Review 7.  Efficacy of Duhuo Jisheng Decoction for Treating Cold-Dampness Obstruction Syndrome-Type Knee Osteoarthritis: A Pooled Analysis.

Authors:  Jinlong Zhao; Guihong Liang; Jianke Pan; Weiyi Yang; Lingfeng Zeng; Jun Liu
Journal:  Biomed Res Int       Date:  2022-06-21       Impact factor: 3.246

8.  Exogenous stromal cell-derived factor-1 (SDF-1) suppresses the NLRP3 inflammasome and inhibits pyroptosis in synoviocytes from osteoarthritic joints via activation of the AMPK signaling pathway.

Authors:  Shuya Wang; Ali Mobasheri; Yue Zhang; Yanli Wang; Tianqi Dai; Zhiyi Zhang
Journal:  Inflammopharmacology       Date:  2021-06-03       Impact factor: 4.473

9.  Alterations in cartilage quantification before and after injections of mesenchymal stem cells into osteoarthritic knees.

Authors:  Ichiro Sekiya; Hisako Katano; Mitsuru Mizuno; Hideyuki Koga; Jun Masumoto; Makoto Tomita; Nobutake Ozeki
Journal:  Sci Rep       Date:  2021-07-05       Impact factor: 4.379

10.  Editorial: One Step at a Time: Advances in Osteoarthritis.

Authors:  Ali Mobasheri; Troy N Trumble; Christopher R Byron
Journal:  Front Vet Sci       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.